Back to search

University of Thessaly (UTH)

Η κλινική αξία της οστεοποντίνης στον καρκίνο του πνεύμονα

Abstract

dc:description

INTRODUCTION: Osteopontin (OPN) is a multifunctional glycoprotein found in various tissues. It plays an important role in physiological and pathological processes, including cancer biology.PURPOSE: The aim of this study was a) to evaluate OPN serum levels in lung cancer patients in comparison with samples from healthy volunteers, b) to correlate pre-treatment OPN serum levels with clinicopathological parameters, response to therapy and overall survival and c) to seek any possible association of OPN levels with circulating vascular endothelial growth factor (VEGF) and matrix metalloproteinase-9 (MMP-9).MATERIALS AND METHODS: In the present study, 90 patients with primary lung cancer were enrolled - mean age 66.22±9.09 years (70 with Non Small Cell Lung Cancer and 20 with Small Cell Lung Cancer) - and 40 healthy subjects were used as a control group. The serum levels of OPN, VEGF and MMP-9 were measured by ELISA (Enzyme-Linked Immunosorbent Assay).RESULTS: OPN serum levels were elevated in lung cancer patients compared to healthy subjects (52.10 ng/ml vs. 22.98 ng/ml, p<0.0001). In addition, smoker patients showed significantly higher levels of OPN and MMP-9 than non-smokers and ex-smokers (p=0.012 and p=0.008, respectively). Also, patients with worse performance status exhibited higher levels of OPN, VEGF and MMP-9 (p=0.0036, p<0.0001 and p=0.0004, respectively). Those who had significant weight loss, displayed higher levels of OPN (p=0.0003). Furthermore, patients without evidence of metastatic disease in the lymph nodes, had lower levels of VEGF and MMP-9 (p=0.0101 and p=0.0144, respectively). There was no association of OPN, VEGF and MMP-9 serum levels with response to chemotherapy. Patients with OPN circulating levels above the median value had worse overall survival (39 weeks vs. 64.6 weeks, p=0.0018, log-rank test). In addition, logistic regression analysis demonstrated that OPN serum levels trended towards being an independent prognostic factor for overall survival (p=0.0656, 95% CI 0.9723-2.6563). Similarly worse overall survival, was found for the individuals with values of VEGF above the median value (43.30 weeks vs. 62.90 weeks, p=0.0065). Finally, OPN serum levels were positively correlated with both VEGF and MMP-9 levels (p=0.0008, Spearman r=0.36, and p<0.0001, Spearman r=0.42, respectively).CONCLUSION: In lung cancer patients, OPN might serve as a prognostic biomarker. Furthermore, the positive correlation between OPN and both VEGF and MMP-9 could implicate new insights in tumour angiogenesis.

Degree

thesis:*
Grantor dc:publisher
University of Thessaly (UTH)
Year dc:date
2016

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Kazakou, Aikaterini
  • Καζάκου, Αικατερίνη

Subjects

dc:subject × 14

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/39378

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Kazakou, Aikaterini; Καζάκου, Αικατερίνη. Η κλινική αξία της οστεοποντίνης στον καρκίνο του πνεύμονα. University of Thessaly (UTH), 2016. http://hdl.handle.net/10442/hedi/39378